PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GPCR vs. AZN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GPCR and AZN is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

GPCR vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Structure Therapeutics Inc. American Depositary Shares (GPCR) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-32.86%
-11.14%
GPCR
AZN

Key characteristics

Sharpe Ratio

GPCR:

-0.60

AZN:

1.09

Sortino Ratio

GPCR:

-0.81

AZN:

1.50

Omega Ratio

GPCR:

0.91

AZN:

1.21

Calmar Ratio

GPCR:

-0.75

AZN:

0.79

Martin Ratio

GPCR:

-1.55

AZN:

1.68

Ulcer Index

GPCR:

32.56%

AZN:

13.16%

Daily Std Dev

GPCR:

83.95%

AZN:

20.37%

Max Drawdown

GPCR:

-67.31%

AZN:

-48.94%

Current Drawdown

GPCR:

-67.25%

AZN:

-15.05%

Fundamentals

Market Cap

GPCR:

$1.42B

AZN:

$225.55B

EPS

GPCR:

-$2.16

AZN:

$2.25

Total Revenue (TTM)

GPCR:

$0.00

AZN:

$54.07B

Gross Profit (TTM)

GPCR:

-$890.66K

AZN:

$43.87B

EBITDA (TTM)

GPCR:

-$110.45M

AZN:

$17.22B

Returns By Period

In the year-to-date period, GPCR achieves a -10.29% return, which is significantly lower than AZN's 13.60% return.


GPCR

YTD

-10.29%

1M

-3.30%

6M

-32.86%

1Y

-47.85%

5Y*

N/A

10Y*

N/A

AZN

YTD

13.60%

1M

13.24%

6M

-11.14%

1Y

24.59%

5Y*

11.96%

10Y*

11.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GPCR vs. AZN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GPCR
The Risk-Adjusted Performance Rank of GPCR is 1111
Overall Rank
The Sharpe Ratio Rank of GPCR is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of GPCR is 1414
Sortino Ratio Rank
The Omega Ratio Rank of GPCR is 1616
Omega Ratio Rank
The Calmar Ratio Rank of GPCR is 66
Calmar Ratio Rank
The Martin Ratio Rank of GPCR is 44
Martin Ratio Rank

AZN
The Risk-Adjusted Performance Rank of AZN is 7171
Overall Rank
The Sharpe Ratio Rank of AZN is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of AZN is 7070
Sortino Ratio Rank
The Omega Ratio Rank of AZN is 7070
Omega Ratio Rank
The Calmar Ratio Rank of AZN is 7575
Calmar Ratio Rank
The Martin Ratio Rank of AZN is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GPCR vs. AZN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Structure Therapeutics Inc. American Depositary Shares (GPCR) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GPCR, currently valued at -0.60, compared to the broader market-2.000.002.004.00-0.601.09
The chart of Sortino ratio for GPCR, currently valued at -0.81, compared to the broader market-6.00-4.00-2.000.002.004.00-0.811.50
The chart of Omega ratio for GPCR, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.21
The chart of Calmar ratio for GPCR, currently valued at -0.75, compared to the broader market0.002.004.006.00-0.750.79
The chart of Martin ratio for GPCR, currently valued at -1.55, compared to the broader market0.0010.0020.0030.00-1.551.68
GPCR
AZN

The current GPCR Sharpe Ratio is -0.60, which is lower than the AZN Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of GPCR and AZN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
-0.60
1.09
GPCR
AZN

Dividends

GPCR vs. AZN - Dividend Comparison

GPCR has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.00%.


TTM20242023202220212020201920182017201620152014
GPCR
Structure Therapeutics Inc. American Depositary Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AZN
AstraZeneca PLC
2.00%2.27%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%

Drawdowns

GPCR vs. AZN - Drawdown Comparison

The maximum GPCR drawdown since its inception was -67.31%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for GPCR and AZN. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-67.25%
-15.05%
GPCR
AZN

Volatility

GPCR vs. AZN - Volatility Comparison

Structure Therapeutics Inc. American Depositary Shares (GPCR) has a higher volatility of 20.97% compared to AstraZeneca PLC (AZN) at 5.56%. This indicates that GPCR's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
20.97%
5.56%
GPCR
AZN

Financials

GPCR vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between Structure Therapeutics Inc. American Depositary Shares and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab